These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel approaches to new therapies for hepatitis B virus infection. Loomba R; Liang TJ Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection. Zoulim F Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174 [TBL] [Abstract][Full Text] [Related]
4. Therapy of chronic hepatitis B: new goals and new treatments. Mauss S Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Liaw YF Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811 [TBL] [Abstract][Full Text] [Related]
7. How to overcome antiviral-resistant hepatitis B virus? Song BC Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338 [TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B in Asia-new insights from the past decade. Chan HL; Jia J J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():131-7. PubMed ID: 21199524 [TBL] [Abstract][Full Text] [Related]
9. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Hofmann WP; Soriano V; Zeuzem S Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus: old, new and future approaches to antiviral treatment. Karayiannis P J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750 [TBL] [Abstract][Full Text] [Related]
11. What is the optimal therapy for chronic hepatitis B? Lyra AC; Di Bisceglie AM Minerva Med; 2001 Dec; 92(6):431-4. PubMed ID: 11740431 [TBL] [Abstract][Full Text] [Related]
12. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV. Locarnini S; Warner N Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179 [TBL] [Abstract][Full Text] [Related]
14. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Wang FS; Zhang Z Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672 [TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy of chronic hepatitis B: prevention of drug resistance. Fournier C; Zoulim F Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233 [TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL; Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260 [TBL] [Abstract][Full Text] [Related]
17. Current treatment and future directions in the management of chronic hepatitis B viral infection. Gish RG Clin Liver Dis; 2005 Nov; 9(4):541-65, v. PubMed ID: 16207563 [TBL] [Abstract][Full Text] [Related]
18. Advances in antiviral agents for hepatitis B virus. Gumina G; Song GY; Chu CK Antivir Chem Chemother; 2001; 12 Suppl 1():93-117. PubMed ID: 11594693 [TBL] [Abstract][Full Text] [Related]
19. Therapy of chronic hepatitis B: today and tomorrow. Trifan A; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):689-98. PubMed ID: 14756005 [TBL] [Abstract][Full Text] [Related]
20. Management of chronic hepatitis B in children. Shah U; Kelly D; Chang MH; Fujisawa T; Heller S; González-Peralta RP; Jara P; Mieli-Vergani G; Mohan N; Murray KF J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):399-404. PubMed ID: 19322053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]